Journal article icon

Journal article

Rapamycin Exerts Its Geroprotective Effects in the Ageing Human Immune System by Enhancing Resilience Against DNA Damage

Abstract:
mTOR inhibitors such as rapamycin are among the most robust life‐extending interventions known, yet the mechanisms underlying their geroprotective effects in humans remain incompletely understood. At non‐immunosuppressive doses, these drugs are senomorphic, that is, they mitigate cellular senescence, but whether they protect genome stability itself has been unclear. Given that DNA damage is a major driver of immune ageing, and immune decline accelerates whole‐organism ageing, we tested whether mTOR inhibition enhances genome stability. In human T cells exposed to acute genotoxic stress, we found that rapamycin and other mTOR inhibitors suppressed senescence not by slowing protein synthesis, halting cell division, or stimulating autophagy, but by directly reducing DNA lesional burden and improving cell survival. Ex vivo analysis of aged immune cells from healthy donors revealed a stark enrichment of markers for DNA damage, senescence, and mTORC hyperactivation, suggesting that human immune ageing may be amenable to intervention by low‐dose mTOR inhibition. To test this in vivo, we conducted a placebo‐controlled experimental medicine study in older adults administered with low‐dose rapamycin. p21, a marker of DNA damage‐induced senescence, was significantly reduced in immune cells from the rapamycin compared to placebo group. These findings reveal a previously unrecognised role for mTOR inhibition: direct genoprotection. This mechanism may help explain rapamycin's exceptional geroprotective profile and opens new avenues for its use in contexts where genome instability drives pathology, ranging from healthy ageing, clinical radiation exposure and even the hazards of cosmic radiation in space travel.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1111/acel.70364

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-1322-2027
More by this author
Role:
Author
ORCID:
0000-0003-3261-3787
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-4650-244X
More by this author
Role:
Author
ORCID:
0000-0001-8808-8243
More by this author
Role:
Author
ORCID:
0000-0001-8971-6635


More from this funder
Funder identifier:
https://ror.org/029chgv08
More from this funder
Funder identifier:
https://ror.org/02jkpm469
More from this funder
Funder identifier:
https://ror.org/03x94j517


Publisher:
Wiley
Journal:
Aging Cell More from this journal
Volume:
25
Issue:
2
Article number:
e70364
Publication date:
2026-01-12
Acceptance date:
2025-12-24
DOI:
EISSN:
1474-9726
ISSN:
1474-9718


Language:
English
Keywords:
Source identifiers:
3655984
Deposit date:
2026-01-12
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP